Skip to content
10-K

Annual Report

CardioGenics Holdings Inc.

0001493152-16-007687

← back to feed
Filed
Feb 26, 2016 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2015 · Feb 12, 2016 92.87M sh
Stock Issued FY 2015 · Oct 31, 2015 1.6M sh
Shares Diluted FY 2015 · Oct 31, 2015 94.42M sh
Shares Diluted FY 2015 · Oct 31, 2014 61.7M sh
Operating Cash Flow FY 2015 · Oct 31, 2015 −$606.64K
Operating Cash Flow FY 2015 · Oct 31, 2014 −$597.11K
Cash And Equivalents FY 2015 · Oct 31, 2015 $49.88K
Cash And Equivalents FY 2015 · Oct 31, 2014 $70.68K
Cash And Equivalents FY 2015 · Oct 31, 2013 $263.1K
Stockholders Equity FY 2015 · Oct 31, 2015 −$1.56M
Stockholders Equity restated FY 2015 · Oct 31, 2014 −$1.12M
Stockholders Equity restated FY 2015 · Oct 31, 2013 −$917.04K
Current Liabilities FY 2015 · Oct 31, 2015 $1.79M
Current Liabilities FY 2015 · Oct 31, 2014 $1.42M
Current Assets FY 2015 · Oct 31, 2015 $52.26K
Current Assets FY 2015 · Oct 31, 2014 $73.53K
Total Assets FY 2015 · Oct 31, 2015 $231.93K
Total Assets FY 2015 · Oct 31, 2014 $269.93K
Sga Expense FY 2015 · Oct 31, 2015 $541.59K
Sga Expense FY 2015 · Oct 31, 2014 $451.47K
Rd Expense FY 2015 · Oct 31, 2015 $215.79K
Rd Expense FY 2015 · Oct 31, 2014 $500.94K
Net Income FY 2015 · Oct 31, 2015 −$1.92M
Net Income FY 2015 · Oct 31, 2014 −$2.68M
Operating Income FY 2015 · Oct 31, 2015 −$772.14K
Operating Income FY 2015 · Oct 31, 2014 −$973.51K